1Cani, PD & Delzenne, NM (2009) Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr Opin Pharmacol 9, 737–743.
2Larsen, N, Vogensen, FK, van den Berg, FWJ, et al. (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5, e9085.
3Caesar, R, Fåk, F & Bäckhed, F (2010) Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med 268, 320–328.
4Herder, C, Schneitler, S, Rathmann, W, et al. (2007) Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab 92, 4569–4574.
5Stoll, G & Bendszus, M (2006) Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 37, 1923–1932.
6Dandona, P, Aljada, A & Bandyopadhyay, A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25, 4–7.
7Pickup, JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27, 813–823.
8Duncan, BB, Schmidt, MI, Pankow, JS, et al. (2003) Low-grade systemic inflammation and the development of type 2 diabetes. Diabetes 52, 1799–1805.
9Libby, P, Ridker, PM & Maseri, A (2002) Inflammation and atherosclerosis. Circulation 105, 1135–1143.
10Cani, PD, Neyrinck, AM, Fava, F, et al. (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374–2383.
11Cani, PD, Amar, J, Iglesias, MA, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772.
12Elson, G, Dunn-Siegrist, I, Daubeuf, B, et al. (2007) Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 109, 1574–1583.
13Wiedermann, CJ, Kiechl, S, Dunzendorfer, S, et al. (1999) Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol 34, 1975–1981.
14Elin, RJ & Wolff, SM (1976) Biology of endotoxin. Annu Rev Med 27, 127–141.
15Hattori, M & Taylor, TD (2009) The human intestinal microbiome: a new frontier of human biology. DNA Res 16, 1–12.
16Brun, P, Castagliuolo, I, Leo, VD, et al. (2007) Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292, G518–G525.
17Berg, RD (1996) The indigenous gastrointestinal microflora. Trends Microbiol 4, 430–435.
18Bayston, K & Cohen, J (1990) Bacterial endotoxin and current concepts in the diagnosis and treatment of endotoxaemia. J Med Microbiol 31, 73–83.
19Laugerette, FC, Vors, A, Geloen, A, et al. (2011) Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutr Biochem 22, 53–59.
20Ghoshal, S, Witta, J, Zhong, J, et al. (2009) Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 50, 90–97.
21Ghanim, H, Sia, CL, Upadhyay, M, et al. (2010) Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and Toll-like receptor expression. J Clin Nutr 91, 940–949.
22Erridge, C, Attina, T, Spickett, CM, et al. (2007) A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86, 1286–1292.
23Heine, H, Rietschel, ET & Ulmer, AJ (2001) The biology of endotoxin. Mol Biotechnol 19, 279–296.
24Rietschel, ET, Kirikae, T, Schade, FU, et al. (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8, 217–225.
25Pussinen, PJ, Havulinna, AS, Lehto, M, et al. (2011) Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 34, 392–397.
26Devaraj, S, Dasu, MR, Park, SH, et al. (2009) Increased levels of ligands of Toll-like receptors 2 and 4 in type 1 diabetes. Diabetologia 52, 1665–1668.
27Miller, MA, McTernan, PG, Harte, AL, et al. (2009) Ethnic and sex differences in circulating endotoxin levels: a novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population. Atherosclerosis 203, 494–502.
28Thuy, S, Ladurner, R, Volynets, V, et al. (2008) Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 138, 1452–1455.
29Creely, SJ, McTernan, PG, Kusminski, CM, et al. (2007) Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292, E740–E747.
30De Bandt, JP, Waligora-Dupriet, AJ & Butel, MJ (2011) Intestinal microbiota in inflammation and insulin resistance: relevance to humans. Curr Opin Clin Nutr Metab Care 14, 334–340.
31Laparra, JM & Sanz, Y (2010) Interactions of gut microbiota with functional food components and nutraceuticals. Pharmacol Res 61, 219–225.
32Delzenne, NM & Cani, PD (2011) Gut microbiota and the pathogenesis of insulin resistance. Curr Diab Rep 11, 154–159.
33Laugerette, F, Vors, C, Peretti, N, et al. (2011) Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation. Biochimie 93, 39–45.
34Ghanim, H, Abuaysheh, S, Sia, CL, et al. (2009) Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal. Diabetes Care 32, 2281–2287.
35Amar, J, Burcelin, R, Ruidavets, JB, et al. (2008) Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr 87, 1219–1223.
36Raetz, CRH & Whitfield, C (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71, 635–700.
37Vreugdenhil, AC, Rousseau, CH, Hartung, T, et al. (2003) Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J Immunol 170, 1399–1405.
38Manco, M, Putignani, L & Bottazzo, GF (2010) Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 31, 817–844.
39Harris, HW, Grunfeld, C, Feingold, KR, et al. (1993) Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 91, 1028–1034.
40Salim, SY & Soderholm, JD (2011) Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis 17, 362–381.
41Shen, L, Su, L & Turner, JR (2009) Mechanisms and functional implications of intestinal barrier defects. Dig Dis 27, 443–449.
42Tso, P & Balint, JA (1986) Formation and transport of chylomicrons by enterocytes to the lymphatics. Am J Physiol 250, G715–G726.
43Kvietys, PR, Specian, RD, Grisham, MB, et al. (1991) Jejunal mucosal injury and restitution: role of hydrolytic products of food digestion. Am J Physiol 261, G384–G391.
44Cani, PD, Bibiloni, B, Knauf, C, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470–1481.
45Ji, Y, Sakata, Y & Tso, P (2011) Nutrient-induced inflammation in the intestine. Curr Opin Clin Nutr Metab Care 14, 315–321.
46Keita, AV & Derholm, JD (2010) The intestinal barrier and its regulation by neuroimmune factors. Neurogastroenterol Motil 22, 718–733.
47Turner, JR (2006) Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol 169, 1901–1909.
48de La Serre, CB, Ellis, CL, Lee, J, et al. (2010) Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol 299, G440–G448.
49Suzuki, T & Hara, H (2010) Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab 12, 7–19.
50Cani, PD, Possemiers, S, Van de Wiele, T, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091–1103.
51Wang, Z, Xiao, G, Yao, Y, et al. (2006) The role of bifidobacteria in gut barrier function after thermal injury in rats. J Trauma 61, 650–657.
52Wang, ZT, Yao, YM, Xiao, GX, et al. (2004) Risk factors of development of gut-derived bacterial translocation in thermally injured rats. World J Gastroenterol 10, 1619–1624.
53Griffiths, EA, Duffy, LC, Schanbacher, FL, et al. (2004) In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig Dis Sci 49, 579–589.
54Ruseler-van Embden, JG, van Lieshout, LM, Gosselink, MJ, et al. (1995) Inability of Lactobacillus casei strain GG, L. acidophilus, and Bifidobacterium bifidum to degrade intestinal mucus glycoproteins. Scand J Gastroenterol 30, 675–680.
55Begley, M, Gahan, CG & Hill, C (2005) The interaction between bacteria and bile. FEMS Microbiol Rev 29, 625–651.
56Quigley, EM & Quera, R (2006) Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 130, S78–S90.
57Sabaté, JM, Jouët, P, Harnois, F, et al. (2008) High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg 18, 371–377.
58Jones, BV, Begley, M, Hill, C, et al. (2008) Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci 105, 13580–13585.
59Parlesak, A, Schaeckeler, S, Moser, L, et al. (2007) Conjugated primary bile salts reduce permeability of endotoxin through intestinal epithelial cells and synergize with phosphatidylcholine in suppression of inflammatory cytokine production. Crit Care Med 35, 2367–2374.
60Lorenzo-Zúñiga, V, Bartolí, R, Planas, R, et al. (2003) Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology 37, 551–557.
61Raimondi, F, Santoro, P, Barone, MV, et al. (2008) Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation. Am J Physiol Gastrointest Liver Physiol 294, G906–G913.
62Araki, Y, Katoh, T, Ogawa, A, et al. (2005) Bile acid modulates transepithelial permeability via the generation of reactive oxygen species in the Caco-2 cell line. Free Radic Biol Med 39, 769–780.
63Musso, G, Gambino, R & Cassader, M (2010) Obesity, diabetes, and gut microbiota. The hygiene hypothesis expanded? Diabetes Care 33, 2277–2284.
64Cordain, L, Eaton, SB, Sebastian, A, et al. (2005) Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 81, 341–354.
65Hotamisligil, GS (2003) Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27, S53–S55.
66Bastard, JP, Maachi, M, Lagathu, C, et al. (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17, 4–12.
67Cani, PD & Delzenne, NM (2011) The gut microbiome as therapeutic target. Pharmacol Ther 130, 202–212.
68Grimaldi, E, Donnarumma, G, Perfetto, B, et al. (2009) Proinflammatory signal transduction pathway induced by Shigella flexneri porins in Caco-2 cells. Braz J Microbiol 40, 701–713.
69Song, MJ, Kim, KH, Yoon, JM, et al. (2006) Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 346, 739–745.
70Moreira, APB & Alfenas, RCG (2012) The influence of endotoxemia on the molecular mechanisms of insulin resistance. Nutr Hosp 27, 382–390.
71Bastos, DHM, Rogero, MM & Arêas, JAG (2009) Mecanismos de ação de compostos bioativos dos alimentos no contexto de processos inflamatórios relacionados à obesidade . Arq Bras Endocrinol Metab 53, 646–656.
72Pan, ZK (2004) Toll-like receptors and TLR-mediated signaling: more questions than answers. Am J Physiol Lung Cell Mol Physiol 286, L918–L920.
73Ding, S & Lund, PK (2011) Role of intestinal inflammation as an early event in obesity and insulin resistance. Curr Opin Clin Nutr Metab Care 14, 328–333.
74Hoehn, KL, Salmon, AB, Hohnen-Behrens, C, et al. (2009) Insulin resistance is a cellular antioxidant defense mechanism. Proc Natl Acad Sci U S A 106, 17787–17792.
75Laron, Z (2009) Insulin and the brain. Arch Physiol Biochem 115, 112–116.
76Shanik, MH, Xu, Y, Skrha, J, et al. (2008) Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes Care 31, S262–S268.
77Dandona, P, Ghanim, H, Bandyopadhyay, A, et al. (2010) Insulin suppresses endotoxin-induced oxidative, nitrosative, and inflammatory stress in humans. Diabetes Care 33, 2416–2423.
78Mehta, NN, McGillicuddy, FC, Anderson, PD, et al. (2010) Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 59, 172–181.
79Agwunobi, AO, Reid, C, Maycock, P, et al. (2000) Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab 85, 3770–3778.
80Chow, L, From, A & Seaquist, E (2010) Skeletal muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction. Metabolism 59, 70–85.
81Boden, G (2008) Obesity and free fatty acids (FFA). Endocrinol Metab Clin North Am 37, 635–646.
82Kovacs, P & Stumvoll, M (2005) Fatty acids and insulin resistance in muscle and liver. Best Pract Res Clin Endocrinol Metab 19, 625–635.
83Wang, Z, Klipfell, E, Bennett, BJ, et al. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57–63.
84Li, L, Messas, E, Batista, EL Jr, et al. (2002) Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 105, 861–867.
85Tuin, A, Huizinga-Van der Vlag, A, van Loenen-Weemaes, AM, et al. (2006) On the role and fate of LPS-dephosphorylating activity in the rat liver. Am J Physiol Gastrointest Liver Physiol 290, G377–G385.
86Bates, JM, Akerlund, J, Mittge, E, et al. (2007) Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in response to the gut microbiota. Cell Host Microbe 2, 371–382.
87Schromm, AB, Brandenburg, K, Loppnow, H, et al. (1998) The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity. J Immunol 161, 5464–5471.
88Lallès, JP (2010) Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutr Rev 68, 323–332.
89Goldberg, RF, Austen, WG Jr, Zhang, X, et al. (2008) Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc Natl Acad Sci U S A 105, 3551–3556.
90Delzenne, NM, Neyrinck, AM & Cani, PD (2011) Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact 10, S10.
91Narisawa, S, Huang, L, Iwasaki, A, et al. (2003) Accelerated fat absorption in intestinal alkaline phosphatase knockout mice. Mol Cell Biol 23, 7525–7530.
92Sefcíková, Z, Hajek, T, Lenhardt, L, et al. (2008) Different functional responsibility of the small intestine to high-fat/high-energy diet determined the expression of obesity-prone and obesity-resistant phenotypes in rats. Physiol Res 57, 467–474.
93Kaur, J, Madan, S, Hamid, A, et al. (2007) Intestinal alkaline phosphatase secretion in oil-fed rats. Dig Dis Sci 52, 665–670.
94Vazquez, CM, Zanetti, R, Santa-Maria, C, et al. (2000) Effects of two highly monounsaturated oils on lipid composition and enzyme activities in rat jejunum. Biosci Rep 20, 355–368.
95Malo, MS, Alam, SN, Mostafa, G, et al. (2010) Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota. Gut 59, 1476–1484.
96DeFronzo, RA (2010) Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 53, 1270–1287.
97Geraldo, JM & Alfenas, RCG (2008) Papel da dieta na prevenção e no controle da inflamação crônica – evidências atuais . Arq Bras Endocrinol Metab 52, 951–967.
98Fleissner, CK, Huebel, N, Abd El-Bary, MM, et al. (2010) Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr 104, 919–929.
99Mekki, N, Charbonnier, M, Borel, P, et al. (2002) Butter differs from olive oil and sunflower oil in its effect on postprandial lipemia and triacylglycerol-rich lipoproteins after single mixed meals in healthy young men. J Nutr 132, 3642–3649.
100Aspenstrom-Fagerlund, B, Ring, L, Aspenstrom, P, et al. (2007) Oleic acid and docosahexaenoic acid cause an increase in the paracellular absorption of hydrophilic compounds in an experimental model of human absorptive enterocytes. Toxicology 237, 12–23.
101Usami, M, Muraki, K, Iwamoto, M, et al. (2001) Effect of eicosapentaenoic acid (EPA) on tight junction permeability in intestinal monolayer cells. Clin Nutr 20, 351–359.
102Laugerette, F, Furet, JP, Debard, C, et al. (2012) Oil composition of high-fat diet affects metabolic inflammation differently in connection with endotoxin receptors in mice. Am J Physiol Endocrinol Metab 302, E374–E386.
103Fernández-Real, JM, Pérez del Pulgar, S, Luche, E, et al. (2011) CD14 modulates inflammation-driven insulin resistance. Diabetes 60, 2179–2186.
104Tsuzuki, Y, Miyazaki, J, Matsuzaki, K, et al. (2006) Differential modulation in the functions of intestinal dendritic cells by long- and medium-chain fatty acids. J Gastroenterol 41, 209–216.
105Shi, H, Kokoeva, MV, Inouye, K, et al. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116, 3015–3025.
106Kono, H, Fujii, H, Asakawa, M, et al. (2003) Protective effects of medium-chain triglycerides on the liver and gut in rats administered endotoxin. Ann Surg 237, 246–255.
107Wong, SW, Kwon, MJ, Choi, AM, et al. (2009) Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 284, 27384–27392.
108Deopurkar, R, Ghanim, H, Friedman, J, et al. (2010) Differential effects of cream, glucose and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 33, 991–997.
109Roberfroid, M, Gibson, GR & Hoyles, L (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104, Suppl. 2, S1–S63.
110Muccioli, GG, Naslain, D, Bäckhed, F, et al. (2010) The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 6, 392.
111Takemura, N, Okubo, T & Sonoyama, K (2010) Lactobacillus plantarum strain no. 14 reduces adipocyte size in mice fed high-fat diet. Exp Biol Med 235, 849–856.